David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.
Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.
PLoS One. 2024 Jun 10;19(6):e0300851. doi: 10.1371/journal.pone.0300851. eCollection 2024.
Cholecystectomy remains the standard management for acute cholecystitis. Given that rates of nonoperative management have increased, we hypothesize the existence of significant hospital-level variability in operative rates. Thus, we characterized patients who were managed nonoperatively at normal and lower operative hospitals (>90th percentile).
All adult admissions for acute cholecystitis were queried using the 2016-2019 Nationwide Readmissions Database. Centers were ranked by nonoperative rate using multi-level, mixed effects modeling. Hospitals in the top decile of nonoperative rate (>9.4%) were classified as Low Operative Hospitals (LOH; others:nLOH). Separate regression models were created to determine factors associated with nonoperative management at LOH and nLOH.
Of an estimated 418,545 patients, 9.9% were managed at 880 LOH. Multilevel modeling demonstrated that 20.6% of the variability was due to hospital factors alone. After adjustment, older age (Adjusted Odds Ratio [AOR] 1.02/year, 95% Confidence Interval [CI] 1.01-1.02) and public insurance (Medicare AOR 1.31, CI 1.21-1.43 and Medicaid AOR 1.43, CI 1.31-1.57; reference: Private Insurance) were associated with nonoperative management at LOH. These were similar at nLOH. At LOH, SNH status (AOR 1.17, CI 1.07-1.28) and small institution size (AOR 1.20, CI 1.09-1.34) were associated with increased odds of nonoperative management.
We noted a significant variability in the interhospital variation of the nonoperative management of acute cholecystitis. Nevertheless, comparable clinical and socioeconomic factors contribute to nonoperative management at both LOH and non-LOH. Directed strategies to address persistent non-clinical disparities are necessary to minimize deviation from standard protocol and ensure equitable care.
胆囊切除术仍然是急性胆囊炎的标准治疗方法。鉴于非手术治疗的比例有所增加,我们假设手术率存在显著的医院间差异。因此,我们对在正常和低手术医院(>90 百分位)接受非手术治疗的患者进行了特征描述。
使用 2016-2019 年全国再入院数据库查询所有急性胆囊炎成人入院患者。采用多水平混合效应模型,根据非手术率对中心进行排名。非手术率排名前十分之一(>9.4%)的医院被归类为低手术医院(LOH);其他医院为非低手术医院(nLOH)。分别建立回归模型,以确定 LOH 和 nLOH 非手术治疗相关因素。
在估计的 418545 名患者中,有 9.9%在 880 家 LOH 接受治疗。多水平模型表明,20.6%的变异性归因于医院因素。调整后,年龄较大(调整后优势比[OR]每增加 1 岁,95%置信区间[CI]1.01-1.02)和公共保险(医疗保险 OR 1.31,CI 1.21-1.43 和医疗补助 OR 1.43,CI 1.31-1.57;参考:私人保险)与 LOH 的非手术治疗相关。在 nLOH 中也存在类似的情况。在 LOH,SNH 状态(OR 1.17,CI 1.07-1.28)和小机构规模(OR 1.20,CI 1.09-1.34)与非手术治疗的几率增加相关。
我们注意到急性胆囊炎非手术治疗的医院间差异存在显著变异性。然而,相似的临床和社会经济因素导致 LOH 和非 LOH 均倾向于非手术治疗。需要制定有针对性的策略来解决持续存在的非临床差异,以尽量减少偏离标准方案,并确保公平护理。